Argentina: On 23 May, the US Department of the Treasury’s Office of Foreign Assets Control (OFAC) identified the Argentina-based Goldpharma Drug Trafficking and Money Laundering Organization (Goldpharma DTO/MLO) as a significant foreign narcotics trafficker pursuant to the Foreign Narcotics Kingpin Designation Act (Kingpin Act). OFAC also designated eight Argentine nationals for their role in the Goldpharma DTO/MLO, as well as nine entities located in Argentina, Colombia, Canada, the UK, and the Netherlands. According to an OFAC press release,
“the Goldpharma DTO/MLO, while physically based in Buenos Aires, Argentina, operates virtually, via a network of online ‘pharmacy’ websites, which sell both legitimate and clandestinely produced Schedule II and Schedule IV narcotics to customers (including Oxycodone, Hydrocodone, and Tramadol), without a prescription”. According to the same statement, Goldpharma sells the vast majority of its illicit opioids to customers located in the US.
End of preview - This article contains approximately 695 words.
Subscribers: Log in now to read the full article
Not a Subscriber?
Choose from one of the following options